These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 488596)

  • 1. [Evaluation of the electrophysiological effects of aprindine in man, with particular regard to the ventricular preexcitation syndrome (author's transl)].
    Vergara G; Disertori M; Molinis G; Inama G; Antonini L; Del Favero A; Stefenelli C; Furlanello F
    G Ital Cardiol; 1979; 9(6):597-606. PubMed ID: 488596
    [No Abstract]   [Full Text] [Related]  

  • 2. [The therapeutic effect of aprindine in treating 9 cases of Wolff-Parkinson-White syndrome associated with auricular fibrillation (author's transl)].
    Wang HZ
    Zhonghua Nei Ke Za Zhi; 1982 Feb; 21(2):96-8. PubMed ID: 7094710
    [No Abstract]   [Full Text] [Related]  

  • 3. Aprindine for treatment of supraventricular tachycardias. With particular application to Wolff-Parkinson-White syndrome.
    Zipes DP; Gaum WE; Foster PR; Rosen KM; Wu D; Amat-Y-Leon F; Noble RJ
    Am J Cardiol; 1977 Oct; 40(4):586-96. PubMed ID: 910722
    [No Abstract]   [Full Text] [Related]  

  • 4. Aprindine.
    Danilo P
    Am Heart J; 1979 Jan; 97(1):119-24. PubMed ID: 364967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Electrophysiological study of aprindine].
    Ponsonnaille J; Marcheix JC; Gras H
    Ann Cardiol Angeiol (Paris); 1978; 27(3):247-50. PubMed ID: 666259
    [No Abstract]   [Full Text] [Related]  

  • 6. [Electrophysiological effects of chloroacetyl ajmaline in Wolff-Parkinson-White syndrome].
    Touboul P; Gressard A; Atallah G; Chatelain MT; Delahaye JP
    Arch Mal Coeur Vaiss; 1978 Jul; 71(7):808-15. PubMed ID: 102281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of refractory arrhythmias by aprindine in patients with the Wolff-Parkinson-White syndrome.
    Reid PR; Greene HL; Varghese PJ
    Br Heart J; 1977 Dec; 39(12):1353-60. PubMed ID: 603737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of aprindine on the induction and termination of supraventricular tachycardia in patients with accessory pathway syndrome].
    Kubota K; Ikeda T; Takata S; Murakami T; Nakamura S; Fujiki A; Higashino A; Hattori N
    Kokyu To Junkan; 1985 Jul; 33(7):913-9. PubMed ID: 4059681
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of aprindine in the treatment of ventricular arrhythmia. Control by multiple long duration ECG recordings (author's transl)].
    Medvedowsky JL; Barnay C; Massat C; Hanvic G
    Ann Cardiol Angeiol (Paris); 1980; 29(3):201-9. PubMed ID: 7447340
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aprindine in oral long-term preventive treatment of recurrent ventricular tachycardia (author's transl)].
    Frank R; Fournial JF; Vedel J; Fontaine G; Dragodanne C; Grosgogeat Y
    Ann Cardiol Angeiol (Paris); 1977; 26(4):335-8. PubMed ID: 329737
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of aprindine in patients with normal and pre-damaged impulse forming and excitation conducting system. Second communication: Conduction times (author's transl)].
    Pantlen H; Runge M; Luckmann E
    Arzneimittelforschung; 1980; 30(2):324-8. PubMed ID: 7378113
    [No Abstract]   [Full Text] [Related]  

  • 12. [Electrophysiological evaluation of the anti-arrhythmia activity of ethmozin and its diethylamine analog in patients with Wolff-Parkinson-White syndrome].
    Shugushev KhKh; Rozenshtraukh LV; Smetnev AS
    Ter Arkh; 1982; 54(5):84-91. PubMed ID: 7048614
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of the repetitive ventricular response: an index of long-term antiarrhythmic effectiveness of aprindine for ventricular tachycardia in man.
    Schaeffer AH; Greene HL; Reid PR
    Am J Cardiol; 1978 Dec; 42(6):1007-12. PubMed ID: 727128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antazoline and auricular fibrillation in the Wolff-Parkinson-White syndrome].
    Montoyo JV; Llamas A; Gausi C
    Rev Esp Cardiol; 1976; 29(1):55-64. PubMed ID: 1257543
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical observations of the new anti-arrhythmic drug aprindine from long-term trend analyses(author's transl)].
    Freyland MD; Steffel D; Hilger HH
    Dtsch Med Wochenschr; 1975 Sep; 100(36):1764-7. PubMed ID: 50917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of clinical efficacy and plasma levels of aprindine.
    Malini PL; Ambrosioni E; Bracchetti D; Magnani B
    Int J Clin Pharmacol Biopharm; 1979 Oct; 17(10):396-403. PubMed ID: 500254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aprindine for intractable dysarrhythmia (author's transl)].
    Fang WH
    Zhonghua Xin Xue Guan Bing Za Zhi; 1980 Sep; 8(3):210-2. PubMed ID: 7307950
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aprindine treatment of ventricular arrhythmias].
    Sellier P
    Coeur Med Interne; 1980; 19(1):67-71. PubMed ID: 7379481
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolongation of cardiac conduction times by intravenous aprindine in man.
    Greene HL; Reid PR; Schaeffer AH
    Am J Cardiol; 1978 Dec; 42(6):1002-6. PubMed ID: 727127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Discrepant effects of oral and intravenous verapamil on A-V conduction in patients with ventricular preexcitation and atrial fibrillation].
    Petri H; Kafka W; Rudolph W
    Herz; 1983 Jun; 8(3):144-52. PubMed ID: 6347850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.